Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1972 Apr;26(2):90–98. doi: 10.1038/bjc.1972.14

Studies on the Antigenicity of Radiation-induced Murine Osteosarcomata

Michael Moore, Dorothy E Williams
PMCID: PMC2008437  PMID: 4556775

Abstract

The immunogenicities of 15 murine osteosarcomata induced with a bone seeking radioisotope (90Sr) in normal and chimaeric CBA mice were studied. Attempts were made to induce tumour-specific immunity in syngeneic mice by treatment with x-irradiated (15,000 rad) tumour or surgical excision of developing subcutaneous tumour grafts. Resistance was evoked against 6 tumours and this was relatively weak. With the remaining tumours, no resistance against the immunizing tumour could be demonstrated, even though the transplantation tests were made highly sensitive by the use of inocula of as few as 2 × 103 cells in pre-irradiated (400 rad) hosts. Sera from mice immunized against each of the tumours were tested against viable cells of the immunizing tumour by indirect immunofluorescence. In no instance did tumour antisera give a convincing reaction with tumour cells although alloantisera raised by hyperimmunization of H-2 identical and H-2 different donors with osteosarcomata consistently gave strongly positive reactions. The results are interpreted as illustrating the weak tumour specific antigenicity of radiation-induced murine osteosarcomata. The possibility that antigenic deficiency is a consequence of immunosurveillance in this tumour system is discussed.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Barker C. R., Embleton M. J., Glaves D., Moore M., Pimm M. V. Demonstration of cell-surface antigens on chemically induced tumors. Ann N Y Acad Sci. 1971 Jun 21;177:268–278. doi: 10.1111/j.1749-6632.1971.tb35056.x. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Embleton M. J. Tumor-specific antigens in 2-acetylaminofluorene-induced rat hepatomas and related tumors. Isr J Med Sci. 1971 Jan;7(1):144–153. [PubMed] [Google Scholar]
  3. Currie G. A., Bagshawe K. D. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer. 1969 Mar;23(1):141–149. doi: 10.1038/bjc.1969.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Finkel M. P., Biskis B. O., Jinkins P. B. Virus induction of osteosarcomas in mice. Science. 1966 Feb 11;151(3711):698–701. doi: 10.1126/science.151.3711.698. [DOI] [PubMed] [Google Scholar]
  5. GRAFFI A., PASTERNAK G., HORN K. H. DIE ERZEUGUNG VON RESISTENZ GEGEN ISOLOGE TRANSPLANTATE UV-INDUZIERTER SARKOME DER MAUS. Acta Biol Med Ger. 1964;12:726–728. [PubMed] [Google Scholar]
  6. Hellström I., Hellström K. E., Evans C. A., Heppner G. H., Pierce G. E., Yang J. P. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A. 1969 Feb;62(2):362–368. doi: 10.1073/pnas.62.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson S. The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice. Br J Cancer. 1968 Mar;22(1):93–104. doi: 10.1038/bjc.1968.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KLEIN G., SJOGREN H. O., KLEIN E. Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients. Cancer Res. 1963 Jan;23:84–92. [PubMed] [Google Scholar]
  9. Klein G. Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture. Cancer Res. 1968 Apr;28(4):625–635. [PubMed] [Google Scholar]
  10. Oettgen H. F., Old L. J., McLean E. P., Carswell E. A. Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs. Nature. 1968 Oct 19;220(5164):295–297. doi: 10.1038/220295a0. [DOI] [PubMed] [Google Scholar]
  11. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  12. PREHN R. T. TUMOR SPECIFIC IMMUNITY TO NONVIRAL TUMORS. Proc Can Cancer Conf. 1963;5:387–395. [PubMed] [Google Scholar]
  13. Pasternak G., Hoffmann F., Graffi A. Growth of diethylnitrosamine-induced lung tumours in syngeneic mice specifically pretreated with x-ray killed tumour tissue. Folia Biol (Praha) 1966;12(4):299–304. [PubMed] [Google Scholar]
  14. Prehn R. T. Tumor-specific antigens of putatively nonviral tumors. Cancer Res. 1968 Jul;28(7):1326–1330. [PubMed] [Google Scholar]
  15. Price C. H., Moore M., Jones D. B. FBJ virus-induced tumours in mice. A histopathological study of FBJ virus tumours and their relevance to murine and human osteosarcoma arising in bone. Br J Cancer. 1972 Feb;26(1):15–27. doi: 10.1038/bjc.1972.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stjernswärd J. Immunodepressive effect of 3-methylcholanthrene. Antibody formation at the cellular level and reaction against weak antigenic homografts. J Natl Cancer Inst. 1965 Nov;35(5):885–892. [PubMed] [Google Scholar]
  17. Stjernswärd J. Immunosuppression by carcinogens. Antibiot Chemother. 1969;15:213–233. [PubMed] [Google Scholar]
  18. WOODRUFF M. F., SYMES M. O. Evidence of loss of tumour-specific antigen on repeatedly transplanting a tumour in the strain of origin. Br J Cancer. 1962 Sep;16:484–488. doi: 10.1038/bjc.1962.55. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES